# Micromet

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/micromet

- Industry: Biotechnology
- Headquarters: Rockville, US
- Website: www.micromet.de
- Total disclosed funding: $45M
- Latest round: Series E (Mar 29, 2001)
- Investors on record: 9

## About

Micromet, Inc. specializes in domain registration and parking services, enabling users to acquire and monetize domain names effectively.Founded in 1993, Micromet, Inc. is based in Rockville, US. The company has undergone a significant transformation and now operates primarily in the domain registration sector. Under the leadership of CEO Foysal Khan, Micromet, Inc. has successfully closed 11 deals, with the most recent being a Trade Sale in October 2003, raising USD 1,160.00 mn from investors including Amgen Inc. The company has no known subsidiaries or parent companies.Micromet, Inc. operates in the domain registration and parking services sector, offering the domain micromet.de for purchase. Their services include dynamic website generation through the Sedo Domain Parking program, which displays automated third-party advertisements. This model serves individuals and businesses looking to establish an online presence or engage in domain monetization.In the most recent year, 2011, Micromet, Inc. reported revenue of USD 21.92 mn, with an EBITDA of USD -78.10 mn, reflecting operational challenges alongside their revenue generation from domain sales and advertising placements.Micromet, Inc. plans to expand its product offerings and enhance its domain registration services. The recent funding raised in October 2003, amounting to USD 72.00 mn, is intended to support these initiatives and facilitate entry into new markets. The company seeks to tap into broader geographic regions and bolster its operational capacity. Specific details regarding product launches or target markets have not been disclosed.

## Funding rounds

- Series E, Mar 29, 2001, $35M — 3i, Abingworth, Atlas Venture, Wellcome Trust, Schroder Ventures, International Biotechnology Trust, Medical Strategy, Advent Life Sciences
- Series D, Apr 17, 2000, $10M — 3i, Abingworth, Atlas Venture, Schroder Ventures
- Series A, Aug 1, 1996 — Atlas Venture, Industrial Development and Investment

## Investors

- Atlas Venture (https://capitalatlas.ai/funds/atlas-venture) — Series A, Series D, Series E
- Industrial Development and Investment (https://capitalatlas.ai/funds/industrial-development-and-investment) — Series A
- 3i (https://capitalatlas.ai/funds/3i) — Series D, Series E
- Abingworth (https://capitalatlas.ai/funds/abingworth) — Series D, Series E
- Schroder Ventures (https://capitalatlas.ai/funds/schroder-ventures) — Series D, Series E
- Wellcome Trust — Series E
- International Biotechnology Trust — Series E
- Medical Strategy — Series E
- Advent Life Sciences (https://capitalatlas.ai/funds/advent-life-sciences) — Series E